• Ralph Lauren Yahoo Finance Rxrx

$707.000 value
$112.00 (15% off)VIPapplied$707.000

Yahoo Finance RXRX reports insider buying of 24,000 shares by executives, which market observers interpret as confidence in upcoming clinical milestones and strategic partnerships. Operates a GPU-based AI cloud platform, and has several other operations In September 2025, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)’s stock surged nearly 7% following progress across key programs and regulatory milestones. A pivotal step was the $12.5 million milestone payment to Rallybio, tied to the advancement of REV102, an investigational ENPP1 inhibitor for the rare disease hypophosphatasia. This achievement underscores the company’s strategy of advancing innovative assets through collaborative development. Yahoo Finance RXRX data indicates market cap at approximately $1.5B, with Q1 revenue up 32% year-over-year. Analysts project short-term upside given the company’s partnership with major pharma for AI-powered pipeline acceleration.

Arrives by Thu. Oct. 9

Eligible for Same-Day Delivery. Order by 12pm.
  • 8
  • 4
  • 3
  • 11
  • 8

Offers & perks

loyallist icon
Join Star Rewards & get free shipping at $39
Exclusions
Not a Star Rewards member? Get free shipping at $49
Exclusions apply